SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001144204-15-066696
Filing Date
2015-11-18
Accepted
2015-11-18 16:08:43
Documents
1
Period of Report
2015-11-16

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT v425127_4.html 4  
1 OWNERSHIP DOCUMENT v425127_4.xml 4 10017
  Complete submission text file 0001144204-15-066696.txt   11366
Mailing Address 442 LITTLEFIELD AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 442 LITTLEFIELD AVENUE SOUTH SAN FRANCISCO CA 94080 650.243.3100
KALOBIOS PHARMACEUTICALS INC (Issuer) CIK: 0001293310 (see all company filings)

IRS No.: 770557236 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1

Mailing Address 330 MADISON AVENUE, 6TH FLOOR NEW YORK NY 10017
Business Address
Shkreli Martin (Reporting) CIK: 0001525354 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35798 | Film No.: 151240846